EUCTR2006-003170-99-IT
Active, not recruiting
Not Applicable
Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration - IVB JSA
IVERSITA DEGLI STUDI DI UDINE0 sitesMarch 15, 2007
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- IVERSITA DEGLI STUDI DI UDINE
- Status
- Active, not recruiting
- Last Updated
- 14 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who are 50 year old or older. Patients willing to sign a written informed consent. Patients with age\-related macular degeneration and subfoveal choroidal neovascularization, primary when the lesion characteristics controindicate standard treatments, i.e. large occult neovascularization, greater than 4 disc areas or recurrent after standard treatment increase of lesione size by 10 and/or visual loss equal or greater than 2 ETDRS lines after photodynamic therapy with verteporfin
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Concomitant ocular disease in the study eye that could affect visual acuity Prior treatment of the study eye with photodinamic therapy, laser photocoagulation within 90 days preceeding day 1 or any other experimental treatmentPrior ocular surgery within 60 days preceeding baseline Uncontrolled blood pressure Previous stroke or myocardial infarction
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Evaluation of safety and efficacy of intravitreal bevacizumab for macular edema, retinal or choroidal neovascularization or neovascular glaucoma - NDMacular oedemaMedDRA version: 6.1Level: HLGTClassification code 10047060EUCTR2006-002351-33-ITAZIENDA OSPEDALIERA ISTITUTI OSPITALIERI DI VERONA
Unknown
Phase 1
To evaluate safety and efficacy of intravitreal Bevaxizumab injection for intraocular neovasculalizatioARMD,BRVO,CRVO,DR,CNVJPRN-UMIN000000647Department of Ophtalmology of Keio University Hospital10
Active, not recruiting
Not Applicable
Safety and efficacy of intravitreal injections of ranibizumab/Lucentis in combination with verteporfin photodynamic therapy (PDT) in patients with choroidal neovascularisation (CNV) secondary to age related macular degeneratioEUCTR2006-002977-33-SIniversity Eye Hospital10
Completed
Not Applicable
Evaluation of treatment options of central serous chorioretinopathyCentral Serous Chorioretinoathy.Central Serous ChorioretinopathyIRCT2017041533448N1Vice chancellor for research, Zahedan University of Medical Sciences30
Recruiting
Not Applicable
Study of the efficacy and safety of intra-retinal arterial fibrinolysis for central retinal artery occlusioCentral Retinal Artery Occlusion(CRAO)JPRN-UMIN000022972Yokohama City University10